Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

701
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
701
Censoring Survival Data01:09

Censoring Survival Data

632
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
632
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

520
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
520
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.3K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.3K
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

484
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
484
Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data01:16

Statistical Inference Techniques in Hypothesis Testing: Parametric Versus Nonparametric Data

572
Statistical inference techniques, paramount in hypothesis testing, differentiate into two broad categories: parametric and nonparametric statistics.
Parametric statistics, as the name suggests, assumes that data follow a specific distribution, often a normal distribution. This assumption enables robust hypothesis testing and estimation. Parametric methods, like the Student's t-test or Goodness-of-fit test, are frequently employed in biostatistics due to their robustness. For instance,...
572

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Signatures of Dark Matter Annihilation in the Galactic Center with HAWC.

Physical review letters·2026
Same author

How Wastewater Monitoring is Helping to Investigate a Hepatitis A Outbreak Linked to Oysters' Consumption.

Food and environmental virology·2026
Same author

Association of fertility traits with markers of oocyte competence in dairy cattle.

Journal of dairy science·2025
Same author

Fetoscopic two-layer closure for open neural tube defects: prospective study of obstetric, surgical and perinatal outcomes in the first 50 cases.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2025
Same author

Ultra-high-energy gamma-ray bubble around microquasar V4641 Sgr.

Nature·2024
Same author

Blood Parameters in Children and Adolescents With Underweight and Atypical Anorexia Nervosa.

The International journal of eating disorders·2024
Same journal

Impact of Information Leakage in Platform Trials With Survival Endpoints on Type I Error Control.

Pharmaceutical statistics·2026
Same journal

Harmonic Fowlkes-Mallows Index for Medical Diagnostics Tests and Optimal Cut-Off Point Selection of Binary Diseases.

Pharmaceutical statistics·2026
Same journal

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same journal

Optimizing Randomization Ratios in Clinical Trials With Survival Endpoints.

Pharmaceutical statistics·2026
Same journal

CUI-MET: A Clinical Utility Index Based Analysis and Decision Framework for Dose Optimization in Multiple-Dose, Multiple-Outcome Randomized Trials.

Pharmaceutical statistics·2026
Same journal

Will the Pharmaceutical Industry Need Statisticians in an AI World?

Pharmaceutical statistics·2026
See all related articles

Related Experiment Video

Updated: Mar 25, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.3K

Bayesian robustness in meta-analysis for studies with zero responses.

F J Vázquez1, E Moreno2, M A Negrín1

  • 1Department of Quantitative Methods and TiDES Institute, University of Las Palmas de GC, Las Palmas de Gran Canaria, 35017, Spain.

Pharmaceutical Statistics
|February 26, 2016
PubMed
Summary
This summary is machine-generated.

This study introduces a new Bayesian meta-analysis model for binomial data, especially useful for rare events. It offers a more robust alternative to normal approximations, improving uncertainty estimation in statistical meta-analysis.

Keywords:
Bayesian inferenceSarmanov and intrinsic link distributionnoninformative priorstesting on meta-parameters

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Related Experiment Videos

Last Updated: Mar 25, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Area of Science:

  • Statistics
  • Biostatistics
  • Bayesian inference

Background:

  • Traditional meta-analysis often uses normal approximations for discrete data, which can be inadequate.
  • Normal approximations may yield poor results with rare events and specific prior distributions.

Purpose of the Study:

  • To propose an alternative Bayesian model for binomial random variables with zero responses.
  • To assess the robustness of meta-analysis results concerning prior distribution choices.
  • To examine the sensitivity of meta-analysis quantities to selected dependence structures.

Main Methods:

  • Developed a Bayesian meta-analysis model for binomial sparse data.
  • Focused on coherence between prior distributions of study parameters and meta-parameters.
  • Applied the model to real-world data with multiple zero responses.

Main Results:

  • The proposed Bayesian model adequately captures uncertainty in discrete data, outperforming normal approximations.
  • Demonstrated improved robustness in meta-analysis, particularly with rare events.
  • Highlighted the importance of prior distribution coherence for reliable results.

Conclusions:

  • The novel Bayesian approach provides a more accurate and robust method for meta-analysis of binomial sparse data.
  • This model is particularly valuable when dealing with rare events and zero-inflated datasets.
  • Offers a straightforward method to evaluate sensitivity to prior structures in meta-analysis.